Your browser doesn't support javascript.
loading
Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease.
Gonc, E N; Ozon, A; Buyukyilmaz, G; Alikasifoglu, A; Simsek, O P; Kandemir, N.
Affiliation
  • Gonc EN; Division of Pediatric Endocrinology, Hacettepe University Faculty of Medicine, 06100, Ankara, Turkey. ngonc@hacettepe.edu.tr.
  • Ozon A; Division of Pediatric Endocrinology, Hacettepe University Faculty of Medicine, 06100, Ankara, Turkey.
  • Buyukyilmaz G; Division of Pediatric Endocrinology, Hacettepe University Faculty of Medicine, 06100, Ankara, Turkey.
  • Alikasifoglu A; Division of Pediatric Endocrinology, Hacettepe University Faculty of Medicine, 06100, Ankara, Turkey.
  • Simsek OP; Division of Pediatric Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Kandemir N; Division of Pediatric Endocrinology, Hacettepe University Faculty of Medicine, 06100, Ankara, Turkey.
Osteoporos Int ; 29(6): 1471-1474, 2018 06.
Article in En | MEDLINE | ID: mdl-29502293

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteitis Deformans / Bone Density Conservation Agents / Zoledronic Acid / Pamidronate Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Infant / Male Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2018 Document type: Article Affiliation country: Turquía Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteitis Deformans / Bone Density Conservation Agents / Zoledronic Acid / Pamidronate Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Infant / Male Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2018 Document type: Article Affiliation country: Turquía Country of publication: Reino Unido